The PE Ratio as of November 2024 (TTM) for Biofrontera Inc. (BFRI) is 0.75

According to Biofrontera Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.75. This represents a change of -166.63% compared to the average of -1.13 of the last 4 quarters.

Biofrontera Inc. (BFRI) Historical PE Ratio (quarterly & annually)

How has BFRI PE Ratio performed in the past?

The mean historical PE Ratio of Biofrontera Inc. over the last ten years is -8.69. The current 0.75 PE Ratio has changed -963.18% with respect to the historical average. Over the past ten years (40 quarters), BFRI's PE Ratio was at its highest in in the March 2022 quarter at 2.56. The PE Ratio was at its lowest in in the December 2020 quarter at -47.42.

Biofrontera Inc. (BFRI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Biofrontera Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biofrontera Inc. (BFRI) Average PE Ratio

How has BFRI PE Ratio performed in the past?

The current PE Ratio of Biofrontera Inc. (BFRI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Biofrontera Inc. (BFRI) PE Ratio vs. Peers

How is BFRI’s PE Ratio compared to its peers?

Biofrontera Inc.’s PE Ratio is greater than Guardion Health Sciences, Inc. (0.65), greater than Shuttle Pharmaceuticals Holdings, Inc. (-0.23), greater than Akanda Corp. (-0.04), greater than China Pharma Holdings, Inc. (-0.70), greater than Sunshine Biopharma, Inc. (-0.71), greater than Acorda Therapeutics, Inc. (-0.00), greater than Lucy Scientific Discovery Inc. (-1.23), greater than Jupiter Wellness, Inc. (-126.12), greater than Petros Pharmaceuticals, Inc. (-0.25), greater than Evoke Pharma, Inc. (-0.99), greater than Cumberland Pharmaceuticals Inc. (-1.37), greater than Agile Therapeutics, Inc. (-0.65), greater than PainReform Ltd. (-0.58), greater than China SXT Pharmaceuticals, Inc. (-0.06), greater than FSD Pharma Inc. (-0.27), greater than Eagle Pharmaceuticals, Inc. (0.34), greater than Regencell Bioscience Holdings Limited (-15.65), less than Procaps Group S.A. (2.68), greater than Incannex Healthcare Limited (-1.70),

Build a custom stock screener for Biofrontera Inc. (BFRI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biofrontera Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biofrontera Inc. (BFRI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biofrontera Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.